Myriad Genetics Inc (MYGN)

MYGN (NASDAQ:Diversified Services) EQUITY
$34.99
pos +0.00
+0.00%
Today's Range: 0.00 - 0.00 | MYGN Avg Daily Volume: 845,900
Last Update: 05/25/16 - 4:00 PM EDT
Volume: 0
YTD Performance: -18.93%
Open: $0.00
Previous Close: $34.99
52 Week Range: $30.30 - $46.24
Oustanding Shares: 70,298,970
Market Cap: 2,449,216,115
6-Month Chart
TheStreet Ratings Grade for MYGN
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 6 5 5 6
Moderate Buy 0 0 0 0
Hold 6 5 5 5
Moderate Sell 0 0 0 0
Strong Sell 2 2 2 2
Mean Rec. 2.38 2.44 2.44 2.33
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 23.54
Price Earnings Comparisons:
MYGN Sector Avg. S&P 500
23.54 23.50 12.90
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-0.96% 1.13% 11.33%
GROWTH 12 Mo 3 Yr CAGR
Revenue -7.10 0.50 0.13
Net Income -54.50 -0.30 -0.10
EPS -52.20 -0.20 -0.06
Earnings for MYGN:
EBITDA 0.16B
Revenue 0.72B
Average Earnings Estimates
Qtr (06/16) Qtr (09/16) FY (06/16) FY (06/17)
Average Estimate $0.38 $0.43 $1.65 $1.78
Number of Analysts 8 6 10 11
High Estimate $0.39 $0.45 $1.66 $1.88
Low Estimate $0.36 $0.41 $1.63 $1.56
Prior Year $0.41 $0.41 $1.45 $1.65
Growth Rate (Year over Year) -7.62% 4.88% 13.72% 7.94%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
The stock still maintains a bullish slant on the daily chart.
Bullish
Aug 25, 2015 | 7:11 AM EDT
MYGN was upgraded from Market Perform to Outperform, Wells Fargo said. Recent meeting with management confirms a better business outloo...
Bearish
Feb 04, 2015 | 7:51 AM EST
MYGN was downgraded from Neutral to Underperform, Credit Suisse said. $30 price target. Estimates also cut, given the company's new gui...
Bullish
Feb 04, 2015 | 7:40 AM EST
MYGN was upgraded from Market Perform to Outperform, JMP Securities said. $50 price target. Stock is attractive, following a 15% declin...
Charting setups in Myriad Genetics, Clovis Oncology and Aegerion Pharma.
Bullish
Apr 02, 2014 | 8:16 AM EDT
MYGN raised its number, Jefferies said. Driven by unexpected boost to BRCA pricing. $33 price target. 
Bullish
Feb 07, 2014 | 8:25 AM EST
MYGN was upgraded from Underperform to Neutral, Credit Suisse said. $29 price target. Base business can hold up better than expected an...
Bullish
Feb 05, 2014 | 7:58 AM EST
MYGN was upgraded from Underperform to Market Perform, JMP Securities said. Company is executing well, despite increased competition.&n...
Bearish
Dec 30, 2013 | 7:41 AM EST
MYGN was downgraded from Market Perform to Underperform, JMP Securities said. $15 price target. BRCA pricing is lower than expected.&nb...
Bearish
Dec 03, 2013 | 8:16 AM EST
MYGN was downgraded from Outperform to Market Perform, JMP Securities said. Company could face lower reimbursement levels.

Columnist Conversations

Bunge (NYSE:BG) declared a $0.42/share quarterly dividend, a 10.5% increase from its prior dividend rate of $0...
Today's strength in ES (Emini S&P 500) ripped above the May 10 high at 2079.75. This invalidates the March...
Record call volume in Craft Brew Alliance after four day rally. Shares up nearly 5% near $9.19 after lifting 9...
Market having another strong day. Energy shares strong as oil tries to broach $50 a barrel. Seeing some con...

REAL MONEY'S BEST IDEAS

News Breaks

Powered by

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.